BIOLINERX LTD-SPONS ADR (BLRX) Stock Price, Quote, News and Overview
NASDAQ:BLRX - Nasdaq - US09071M2052 - ADR - Currency: USD
BLRX Quote, Performance and Key Statistics
3.59
-0.29 (-7.47%)
The current stock price of BLRX is 3.59 USD. In the past month the price decreased by -22.56%. In the past year, price decreased by -92.39%.
BLRX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About BLRX
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Company Info
BIOLINERX LTD-SPONS ADR
Modi'in Technology Park, 2 HaMa'ayan Street
Modiin 7177871 IL
CEO: Philip A. Serlin
Employees: 79
Company Website: https://www.biolinerx.com/
Investor Relations: http://ir.biolinerx.com/phoenix.zhtml?c=208785&p=irol-IRHome
Phone: 97286429100
BIOLINERX LTD-SPONS ADR / BLRX FAQ
What is the stock price of BIOLINERX LTD-SPONS ADR today?
The current stock price of BLRX is 3.59 USD. The price decreased by -7.47% in the last trading session.
What is the ticker symbol for BIOLINERX LTD-SPONS ADR stock?
The exchange symbol of BIOLINERX LTD-SPONS ADR is BLRX and it is listed on the Nasdaq exchange.
On which exchange is BLRX stock listed?
BLRX stock is listed on the Nasdaq exchange.
What is BIOLINERX LTD-SPONS ADR worth?
BIOLINERX LTD-SPONS ADR (BLRX) has a market capitalization of 12.78M USD. This makes BLRX a Nano Cap stock.
How many employees does BIOLINERX LTD-SPONS ADR have?
BIOLINERX LTD-SPONS ADR (BLRX) currently has 79 employees.
What are the support and resistance levels for BIOLINERX LTD-SPONS ADR (BLRX) stock?
BIOLINERX LTD-SPONS ADR (BLRX) has a support level at 3.32 and a resistance level at 4.12. Check the full technical report for a detailed analysis of BLRX support and resistance levels.
Should I buy BIOLINERX LTD-SPONS ADR (BLRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BLRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BLRX, evaluating the profitability, health, valuation and growth aspects
- BIOLINERX LTD-SPONS ADR (BLRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOLINERX LTD-SPONS ADR (BLRX) Sales and EPS estimates to see what analysts future expectations are.
- BIOLINERX LTD-SPONS ADR (BLRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOLINERX LTD-SPONS ADR (BLRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOLINERX LTD-SPONS ADR (BLRX) Stock Chart to make your own analysis
- BIOLINERX LTD-SPONS ADR (BLRX) Latest news and press-releases to stay up to date.
Does BIOLINERX LTD-SPONS ADR (BLRX) stock pay dividends?
BLRX does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOLINERX LTD-SPONS ADR (BLRX)?
BIOLINERX LTD-SPONS ADR (BLRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.53).
BLRX Technical Analysis
BLRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BLRX. BLRX may be in some trouble as it scores bad on both profitability and health.
BLRX Financial Highlights
Over the last trailing twelve months BLRX reported a non-GAAP Earnings per Share(EPS) of -15.53. The EPS decreased by -30.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -95.25% | ||
| ROE | -376.32% | ||
| Debt/Equity | 0.55 |
BLRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to BLRX. The Buy consensus is the average rating of analysts ratings from 2 analysts.